Clinical Trial

Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50

Study acronym: 50-CENT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 2, 2026 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.
Summary
The objective of this study is to evaluate the risk of inflammatory disease activity by retrospectively comparing two therapeutic strategies (escalation group and induction group). The investigators also aim to identify factors associated with inflammatory relapse and treatment-related complications.
Trial Details
NCT Number NCT07313462
Lead Sponsor University Hospital, Strasbourg, France
Conditions Multiple Sclerosis (MS)
Enrollment 830 participants
Start Date 2025-02-07
Primary Completion 2026-02 (estimated)
Study Completion 2026-02 (estimated)
Updated on ClinicalTrials.gov 2026-01-02